Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.

CNBC

United States

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold

Ad Fontes Media

All Sides

Media Bias/Fact Check

Roberts family

Moderna Inc.’s stock jumped 5% early Thursday, after the company’s third-quarter earnings showed an unexpected profit and revenue that beat estimates by a wide margin.

MarketWatch

Murdoch family

Moderna’s stock pops after biotech ekes out profit and revenue beats by a wide margin

By Patrick  Wingrove (Reuters) –     Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its COVID-19 vaccine, even with low revenue from its new respiratory syncytial virus shot. The Cambridge, Massachusetts-based company posted a profit of $13 million, or 3 cents a share, for the quarter, compared to a loss of $3.6 billion a year ago. Analysts had expected a loss of $753 millio…

Blue Water Healthy Living

Port Huron

St. Clair County

Michigan

Moderna reports surprise profit on higher-than-expected COVID vaccine sales - Blue Water Healthy Living

Moderna crushed third-quarter views on Thursday and turned around a surprise profit, but Moderna stock could slump on light RSV vaccine sales. The post Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing? appeared first on Investor's Business Daily.

Investor's Business Daily

Moderna Posts A Surprise Gain As Sales Wallop Views. But RSV Lags.

MODERNA reported a surprise third-quarter profit on Thursday (Nov 7), driven by cost cutting and higher-than-expected sales of its Covid-19 vaccine, even with low revenue from its new respiratory syncytial virus shot.

Business Times

Moderna reports surprise profit on higher-than-expected Covid vaccine sales

Moderna on Thursday printed a shock income for the third quarter, smashing Wall Street approximates, as its cost-cutting initiatives held and gross sales of its Covid injection might be discovered in additional than anticipated.  The biotech enterprise printed a take-home pay of $13 million, or 3 cents per share, for the third quarter. That compares to a backside line of $3.63 billion, or $9.53 cents per share, reported for the year-ago length. …

India Daily Mail

Moderna (MRNA) incomes Q3 2024

Empty bottles of Moderna’s Covid-19 vaccine. Fred Tanneau | AFP | Getty Images    
Moderna on Thursday posted a surprise profit for the third quarter, smashing Wall Street estimates, as its cost-cutting efforts took hold and sales of its Covid vaccine came in higher than expected.  The biotech company posted net income of $13 million, or 3 cents per share. That compares with a net loss of $3.63 billion, or $9.53 cents per share, reported for the…

Stockxpo - A professional network of traders, investors and analysts

Moderna reported a surprising third-quarter profit on Thursday, driven by cost reductions and stronger-than-expected sales of its COVID-19 vaccine, despite lower-than-anticipated revenue from its new respiratory syncytial virus (RSV) vaccine.  Shares of the Cambridge, Massachusetts-based company jumped 11% in premarket trading. For the quarter, Moderna posted a profit of $13 million, or 3 cents per share, compared to a loss of $3.6 billion in th…

Invezz

Moderna posts surprise profit as COVID vaccine sales exceed expectations

In this articleMRNAFollow your favorite stocksCREATE FREE ACCOUNTEmpty bottles of Moderna’s Covid-19 vaccine.Fred Tanneau | AFP | Getty ImagesModerna on Thursday posted a surprise profit for the third quarter, smashing Wall Street estimates, as its cost-cutting efforts took hold and sales of its Covid vaccine came in higher than expected. The biotech company posted a net income of $13 million, or 3 cents per share, for the third quarter. That co…

RocketNews

Even Moderna itself was surprised by how much profit it posted in the third quarter after selling far more coronavirus vaccines than it had forecast. The Moderna ... ...

Még maga a Moderna is meglepődött azon, mekkora nyereséget könyvelt el a harmadik negyedévben, miután sokkal több koronavírus oltóanyagot értékesített, mint amennyit előre jelzett. A Moderna ... ...

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics